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Introduction 
Acute liver failure (ALF) is a life-threatening illness with over 80% mortality (Bernal and Wendon, 
2013), and the preferred treatment is liver transplantation (Germani et al., 2012). However, transplantation 
is not universally available—with < 10% performed in patients with ALF (Germani et al., 2012; Simpson et 
al., 2009), and HLA unmatching transplantation would increase the risk of death (Bernal et al., 2009; 
Germani et al., 2012). Previous studies have developed a macro liver organoid (LO) from hiPSCs with 
endothelial cells (ECs) and mesenchymal cells (MCs) by mimicing early liver organogenesis, which 
provided a potential approach for liver disease treatment (Camp et al., 2017; Takebe et al., 2013). However, 
this LO was generated with three different donors’ cells with different HLA types, and thus could not match 
any particular patient’s HLA for clinical application. Here, we were going to generate a single donor cells 
derived liver organoid (SDC-LO) from a single donor derived hiPSC, endothelial cells and mesenchymal 
cells with only one HLA type, and investigated this orgnaoid potenial application in ALF mice models.  
 
Material and methods 
Single donor derived ECs and MCs were obtained from a single donor umbilical cord (UC) through enzyme 
digestion, and characterized by flow cytometry. By using a non-viral reprogramming method, we generated 
the same donor derived hiPSC from the UC-ECs, and investigated their hepatic differentiation ability. Finally, 
we simultaneously plated EC-hiPSC endoderm, UC-ECs, and UC-MCs in a three-dimensional (3D) 
microwell culture system to generate functional single donor cells derived LOs for ALF mouse treatment. 
 
Results 
Single donor-derived UC-ECs and UC-MCs promote hiPSC-LO differentiation 
We first isolated UC-ECs and UC-MCs from a single umbilical cord by digestion with an enzyme or an 
enzyme cocktail. UC-ECs demonstrated equal capacity for vascular network formation, proliferation rate 
and cell surface markers compared to commerical ECs (con-EC), and UC-MCs had same cell surface 
markers expression but had a higher proliferative capacity than commerical BM-MSCs (con-MCs). To 
generate function transplants, we used a 3D microwell culture system to promote LOs differentiatio and 
generate small LOs about 200µm. Those UC-ECs and UC-MCs can promote LOs differentiation as 
effectively as con-ECs and con-MCs. 
 
Reprogramming UC-EC into hiPSC with capacity of hepatic lineages differentiation 
Then, we reprogramed UC-ECs into hiPSCs by transfection of episomal hiPSC reprogramming vectors in 
UC-ECs (Okita et al., 2013),  the results EC-hiPSC showed morphology typical of embryonic stem cells 
with nuclear expression of OCT4, NANOG, and SOX2. Gene and FACS analysis confirmed that the EC-
hiPSC could be effectively differentiated into endoderm with high purity (>99%), and this endoderm could 
be further differentiated into hepatic like cells.  
 
SDC-LO generation from single donor-derived hiPSC-endoderm, ECs and MCs 
Next, we generated SDC-LO with single donor-derived EC-hiPSC-endoderm, UC-ECs, and UC-MCs in a 
3D microwell culture plate. The three cell types self-organized into organoids after 24 h of culture, and the 
SDC-LOs maintained an organoid morphology after 15 days differentiation. Compared with EC-hiPSC-
derived HLCs, differentiated SDC-LOs demonstrated much higher hepatic function. Some capacitis could 
reach a level similar to that in PHHs.. 
 
Functional SDC-LOs improve survival in ALF model mice  
To investigate the potential application of functional SDC-LOs in ALF treatment, we transplanted these 
functional SDC-LOs into the renal subcapsular space of ALF mice (Zhang et al., 2015), and found that the 
survival rate was significantly increased compared that of the sham group. Indeed, 70% of mice showed 
recovery from ALF upon SDC-LO transplantation. In SDC-LO transplanted ALF mice, the injured liver was 
undergoing a regeneration process with enlarged hepatocyte and increased hepatic nuclear size. After 2 days 
of transplantation, human ALB can be detected in mice serum with 1128 ± 338.1 ng/ml. These results 
indicate that differentiated SDC-LOs could rapidly perform hepatic functions in ALF mice, and improve the 
microenvironment for liver regeneration to promote recovery from ALF.  
 
Discussion 
The liver is the major organ for the detoxification of various metabolites. In ALF patients, rapid loss of liver 
metabolic function results in accumulation of toxic metabolites that cause further injury to the body (Bernal 
and Wendon, 2013). To eliminate toxic metabolites, researcher have developed some bioartificial liver 
support system to prolong survival in a ALF models (Shi et al., 2016). Here, we found that transplanted 
SDC-LOs could rapidly perform hepatic functions, and promote liver regeneration and survival. These 
findings indicate that SDC-LOs might perform metabolic detoxification and synthetic functions in ALF mice 
and eliminate accumulation of toxic metabolites to provide a healthy microenvironment for liver 
regeneration, finally improving survival. The ability of the SDC-LOs to quickly perform their hepatic 
functions might be attributable to the 3D suspension culture system, which enable collection of organoids 
without enzyme treatment and maximally preserved liver organoid function for transplantation. This simple 
collection method also makes it possible to collect functional organoids produced on a large scale in a short 
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